Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (2): 20-28.doi: 10.6040/j.issn.1671-7554.0.2023.0987
• Preclinical Medicine • Previous Articles
ZHAO Zihui1,2,3*, WANG Xuyang2,3,4*, ZHANG Peng5, FANG Ningning5, SHI Duanbo6, YANG Fan2,3, YANG Xiaomei5, WU Jianbo2,3
CLC Number:
[1] Olsson KM, Corte TJ, Kamp JC, et al. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management[J]. Lancet Respir Med, 2023, 11(9): 820-835. [2] Johnson S, Sommer N, Cox-Flaherty K, et al. Pulmonary hypertension: a contemporary review[J]. Am J Respir Crit Care Med, 2023, 208(5): 528-548. [3] Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2022, 43(38): 3618-3731. [4] Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2023, 61(1): 2200879. doi: 10.1183/13993003.00879-2022. [5] Jani V, Aslam MI, Fenwick AJ, et al. Right ventricular sarcomere contractile depression and the role of thick filament activation in human heart failure with pulmonary hypertension[J]. Circulation, 2023, 147(25): 1919-1932. [6] Bauersachs J, Olsson KM. Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?[J]. Eur Heart J, 2022, 43(36): 3414-3416. [7] Ambroz D, Jansa P, Kuchar J, et al. Predictors of survival in patients with pulmonary hypertension and acute right heart failure[J]. Bratisl Lek Listy, 2020, 121(3): 230-235. [8] Chang KY, Duval S, Badesch DB, et al. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry[J]. J Am Heart Assoc, 2022, 11(9): e024969. doi: 10.1161/JAHA.121.024969. [9] Maron BA, Brittain EL, Hess E, et al. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study[J]. Lancet Respir Med, 2020, 8(9): 873-884. [10] Boucherat O, Agrawal V, Lawrie A, et al. The latest in animal models of pulmonary hypertension and right ventricular failure[J]. Circ Res, 2022, 130(9): 1466-1486. [11] Bueno-Beti C, Sassi Y, Hajjar RJ, et al. Pulmonary artery hypertension model in rats by monocrotaline administration[J]. Methods Mol Biol, 2018, 1816: 233-241. doi:10.1007/9781-4939-8597-5-18. [12] 张栾, 陈欧, 栾云, 等. Gemigliptin对野百合碱诱导的肺动脉高压大鼠治疗作用及炎症因子的影响[J]. 山东大学学报(医学版), 2017, 55(5): 19-22. ZHANG Luan, CHEN Ou, LUAN Yun, et al. Effects of gemigliptin on the therapeutic effect and inflammatory factors of monocrotaline-induced pulmonary arterial hypertension in rats[J]. Journal of Shandong University(Health Sciences), 2017, 55(5): 19-22+30. [13] 彭小飞, 劳金泉, 刘冬立, 等. 右心室经胸穿刺测压法在肺动脉高压大鼠模型中的应用[J]. 中南医学科学杂志, 2018, 46(2): 197-200. PENG Xiaofei, LAO Jinqun, LIU Dongli, et al. Application of right ventricle pressure by right ventricle punctured through ghest in pulmonary hypertension rats model[J]. Medical Science Journal of Central South China, 2018, 46(2): 197-200. [14] Nickel NP, Yuan K, Dorfmuller P, et al. Beyond the lungs: systemic manifestations of pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2020, 201(2): 148-157. [15] Mamazhakypov A, Hein L, Lother A. Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting[J]. Pharmacol Ther, 2022, 231: 107987. doi: 10.1016/j.pharmthera.2021.107987. [16] Zhou X, Jiang Y, Wang Y, et al. Endothelial FIS1 DeSUMOylation protects against hypoxic pulmonary hypertension[J]. Circ Res, 2023, 133(6): 508-531. [17] Sangam S, Sun X, Schwantes-An TH, et al. SOX17 deficiency mediates pulmonary hypertension: at the crossroads of sex, metabolism, and genetics[J]. Am J Respir Crit Care Med, 2023, 207(8): 1055-1069. [18] Cunningham CM, Li M, Ruffenach G, et al. Y-Chromosome Gene, Uty, protects against pulmonary hypertension by reducing proinflammatory chemokines[J]. Am J Respir Crit Care Med, 2022, 206(2): 186-196. [19] Balistrieri A, Makino A, Yuan JX. Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca(2+)signaling[J]. Physiol Rev, 2023, 103(3): 1827-1897. [20] Lin Q, Kumar S, Kariyawasam U, et al. Human resistin induces cardiac dysfunction in pulmonary hypertension[J]. J Am Heart Assoc, 2023, 12(6): e027621. doi: 10.1161/JAHA.122.027621. [21] Kwan ED, Vélez-Rendón D, Zhang X, et al. Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension[J]. Am J Physiol Heart Circ Physiol, 2021, 321(4): H702-H715. [22] Otto CM, Bartkowiak J, Hahn RT. Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe[J]. Heart, 2023. doi: 10.1136/heartjnl-2023-323230. [23] Thibault HB, Kurtz B, Raher MJ, et al. Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension[J]. Circ Cardiovasc Imaging, 2010, 3(2): 157-163. [24] Al-Qazazi R, Lima PDA, Prisco SZ, et al. Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2022, 206(5): 608-624. [25] Wu Z, Zhu L, Nie X, et al. USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner[J]. Exp Mol Med, 2023, 55(1): 183-195. [26] Zhang X, Li J, Zeng D, et al. A novel method for measuring pulmonary artery pressure by high-frequency ultrasound-guided transthoracic puncture in rats[J]. Front Cardiovasc Med, 2022, 9: 995728. doi: 10.3389/fcvm.2022.995728. [27] 董政委, 樊官伟. 改良右心导管法测量大鼠肺动脉压力综述[J]. 实验动物与比较医学, 2020, 40(4): 354-359. DONG Zhengwei, FAN Guanwei. A review of modified right heart catheterization for measuring pulmonary artery pressure in rats[J]. Laboratory Animal and Comparative Medicine, 2020, 40(4): 354-359. [28] Krishnan A, Markham R, Savage M, et al. Right heart catheterisation: how to do it[J]. Heart Lung Circ, 2019, 28(4): e71-e78. |
[1] | ZHU Lin, HU San-Yuan, ZHANG Guang-Yong, DING Xiang-Jiu. Protection of PGE2 against intestinal mucosa injuries in obstructed jaundice rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 12-. |
[2] | SUN Tao, ZHANG Dao-Lai, XIE Shan-Shan, WANG Yu-Zhuo, FENG Yu-Xin, XIN Hua. Effect of ethanol on expression of connexin 43 in primary culture of neural precursor cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 20-. |
[3] | ZHANG Dao-Lai, SUN Tao, XIE Shan-Shan, WANG Yu-Zhuo, ZHAO Ling, FENG Yu-Xin, XIN Hua. Developmental expression of NMDAR1 subunit on cultured cerebral cortical neurons of fetal rats in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 28-32. |
[4] | HU Na, SUN Miao, XING Shasha, XU Danxia, HAI Xiaoming, MA Ling, YANG Li, MIAN Yuchen, HE Rui, CHEN Dongmei, MA Huiming. Evening primrose oil resists oxidative stress in the ovaries of rats with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 22-30. |
[5] | ZHAO Huiwen, XU Lin, SHAN Shan, ZHAO Xiulan. Protective effect of taurine on cognitive deficit induced by 1-bromopropane [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 14-21. |
[6] | WANG Haipeng, ZOU Juanjuan, GAO Chunmiao, WANG Xiao, WANG Yan, LI Yanzhong. Construction and significance of a rat model of OSAHS with chronic intermittent hypoxia [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 7-13. |
[7] | AN Yuanxiaoxue, ZHAO Yuying, ZHAO Cuifen, XU Ruiying, XUE Yuwen. Pulmonary hypertension in combined methylmalonic acidemia: a report of two cases and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 103-109. |
[8] | JIA Mingwang, LIAO Guangyuan, XIONG Mingmei, XU Wenting, WANG Yinling, WANG Yichun. Clinical analysis of outcomes of 84 pregnant women with pulmonary hypertension [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 34-39. |
[9] | ZHANG Jijuan, YU Hancheng, WANG Lan, CHEN Nuo, CUI Shumeng, Gao Xibao. Effects of high-fat diet and selenium concentration on antioxidant function in rats [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 95-101. |
[10] | DING Hualin, LI Yangyang, YU Fengyuan, ZHAN Weiwei, YU Suguo. Daglixamine inhibits renal fibrosis in rats with diabetic nephropathy via Klotho/TGF-β1 signaling pathway [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 75-80. |
[11] | ZHANG Meiling, SUN Hui, SUN Wenkai, MENG Zhaotun, WU Xinfang, GAO Wei, LI Qin. Effects of intranasal infusion of IFN-γ on Th17/Treg cells in peripheral blood of rats with allergic rhinitis [J]. Journal of Shandong University (Health Sciences), 2020, 58(1): 13-19. |
[12] | DU Hao, CHENG Yugang, HUANG Xin, LIU Shaozhuang, ZHANG Guangyong, HU Sanyuan. Effects of sleeve gastrectomy on lung injury in type 2 diabetic rats [J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 20-26. |
[13] | SONG Lijin, GU Xiang, LI Lixiang, LI Ming, ZUO Xiuli, LI Yanqing. Effects of Fusobacterium nucleatum gavage on the intestinal microbiota of rats [J]. Journal of Shandong University (Health Sciences), 2018, 56(7): 7-14. |
[14] | ZHANG Dandan, XIE Hongqiang, WU Qianqian, LI Hongchang, ZHU Yueting, LU Juanjuan, JIANG Wenjie, YAN Junhao. Clinical treatment value of preimplantation genetic screening for unexplained repeated implantation failure [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 64-69. |
[15] | WANG Qianqian, WANG Xuxia, QIAO Qingfang, WANG Yingzi, YANG Panpan, ZHANG Jun. Effects of sympathetic signals on orthodontic root resorption in rats [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 76-80. |
|